Isothermal Nucleic Acid Amplification for Point-of-Care Primary Cervical Cancer Screening
Viruses · 2024
DOI: 10.3390/v16121852 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, 2024. Verfasst von Maryame Lamsisi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Biotechnology Unit, Institut Pasteur du Maroc, Casablanca 20360, Morocco. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Nucleic Acid Amplification Techniques, Early Detection of Cancer, Papillomavirus Infections. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Human Papillomavirus (HPV) infection is a significant global health concern linked to various cancers, particularly cervical cancer. Timely and accurate detection of HPV is crucial for effective management and prevention strategies. Traditional laboratory-based HPV testing methods often suffer from limitations such as long turnaround times, restricted accessibility, and the need for trained personnel, especially in resource-limited settings. Consequently, there is a growing demand for point-of-care (POC) HPV testing solutions that offer rapid, easy-to-use, and convenient screening at the primary care level. This review provides a comprehensive overview of recent advancements and emerging technologies utilized in POC HPV testing using isothermal amplification methods, in addition to evaluating their diagnostic performance, sensitivity, specificity, and clinical utility compared to conventional laboratory-based assays, particularly in low-resource settings, where access to centralized laboratory facilities is limited. We provide insights into the potential of isothermal nucleic acid amplification to revolutionize cervical cancer screening and prevention efforts worldwide, with emphasis on the need for continued research, innovation, and collaboration to optimize the performance, accessibility, and affordability of POC HPV testing solutions, ultimately contributing to the worldwide effort towards the elimination of this disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biotechnology Unit, Institut Pasteur du Maroc, Casablanca 20360, Morocco.
- Department of Obstetrics & Gynecology, Mohamed V Military Instruction Hospital of Rabat, Rabat 10045, Morocco.
- Laboratory of Virology, Mohamed V Military Instruction Hospital of Rabat, Rabat 10045, Morocco.
- Laboratory of Virology, Oncology, Biosciences, Environment, and New Energies, Faculty of Sciences and Techniques Mohammedia, Mohammedia 20650, Morocco.
- Department of Obstetrics & Gynecology, North Hospital, Centre Hospitalier Universitaire Saint Etienne, 42055 Saint Etienne, France.
- Laboratory of Virology, North Hospital, CHU Saint Etienne, 42055 Saint Etienne, France.
ORCID-Profile: Maryame Lamsisi, Abdelilah Laraqui, Guorong Li
Zitieren
APA
Lamsisi, M., Benlghazi, A., Kouach, J., Laraqui, A., Ennaji, M. M., Chauleur, C., Bourlet, T., & Li, G. (2024). Isothermal Nucleic Acid Amplification for Point-of-Care Primary Cervical Cancer Screening. Viruses. https://doi.org/10.3390/v16121852
Vancouver
Lamsisi M, Benlghazi A, Kouach J, Laraqui A, Ennaji MM, Chauleur C, et al. Isothermal Nucleic Acid Amplification for Point-of-Care Primary Cervical Cancer Screening. Viruses. 2024. doi:10.3390/v16121852
BibTeX
@article{Lamsisi2024,
author = {Lamsisi, Maryame and Benlghazi, Abdelhamid and Kouach, Jaouad and Laraqui, Abdelilah and Ennaji, Moulay Mustapha and Chauleur, Céline and Bourlet, Thomas and Li, Guorong},
title = {Isothermal Nucleic Acid Amplification for Point-of-Care Primary Cervical Cancer Screening},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16121852}
}
EUVIMED